Nkarta Inc. (NKTX) NASDAQ

$15.53 0.28 (1.80%)

Market Cap: $502.48M

As of 11/30/21 09:30 AM EST. Market open.

(NKTX)

Nkarta Inc. (NKTX) NASDAQ

$15.53 0.28 (1.80%)

Market Cap: $502.48M

As of 11/30/21 09:30 AM EST. Market open.

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance ... read more

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance tumor targeting and improve persistence for sustained activity in the body. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
95
Address
.
KEY STATS
Open
$15.53
Previous Close
$15.25
Days Range
$15.10 - $16.76
52 week range
$15.10 - $79.16
Volume
5,344
Avg. Volume (30 days)
289,097
Market Cap
$502.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,949,415
Open
$15.53
Previous Close
$15.25
Days Range
$15.10 - $16.76
52 week range
$15.10 - $79.16
Volume
5,344
Avg. Volume (30 days)
289,097
Market Cap
$502.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,949,415

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NKARTA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
HASTINGS PAUL J Chief Executive Officer Sep 29, 2021 Sale $27.18 8,500 231,051 219,284 Oct 01, 2021, 04:35 PM
Brandenberger Ralph See Remarks Sep 01, 2021 Option Exercise $3.69 4,140 15,278 4,140 Sep 02, 2021, 08:52 PM
Brandenberger Ralph See Remarks Sep 01, 2021 Sale $32.08 4,140 132,811 0 Sep 02, 2021, 08:52 PM
Rajangam Kanya Chief Medical Officer Aug 05, 2021 Option Exercise $0.41 10,000 4,100 10,000 Aug 09, 2021, 05:17 PM
Rajangam Kanya Chief Medical Officer Aug 05, 2021 Sale $37.28 10,000 372,800 0 Aug 09, 2021, 05:17 PM
Trager James Chief Scientific Officer Aug 02, 2021 Option Exercise $3.89 2,250 8,753 47,972 Aug 04, 2021, 04:50 PM
Trager James Chief Scientific Officer Aug 02, 2021 Sale $31.53 3,600 113,508 44,372 Aug 04, 2021, 04:50 PM
Mahmood Nadir See Remarks Jul 01, 2021 Option Exercise $3.89 3,500 13,615 33,788 Jul 06, 2021, 05:11 PM
Mahmood Nadir See Remarks Jul 01, 2021 Sale $31.71 6,500 206,115 27,288 Jul 06, 2021, 05:11 PM
HASTINGS PAUL J Chief Executive Officer Jun 21, 2021 Sale $26.61 8,500 226,218 231,368 Jun 23, 2021, 04:05 PM
Brandenberger Ralph See Remarks Jun 02, 2021 Option Exercise $3.69 4,140 15,278 4,140 Jun 04, 2021, 02:29 PM
Brandenberger Ralph See Remarks Jun 02, 2021 Sale $24.50 4,140 101,430 0 Jun 04, 2021, 02:29 PM
HASTINGS PAUL J Chief Executive Officer Mar 30, 2021 Sale $30.74 17,000 522,540 241,600 Apr 01, 2021, 06:15 AM
Trager James Chief Scientific Officer Feb 02, 2021 Option Exercise $18.00 2,800 50,400 49,872 Feb 03, 2021, 07:48 PM
Trager James Chief Scientific Officer Feb 01, 2021 Option Exercise $3.89 2,250 8,753 50,672 Feb 03, 2021, 07:48 PM
Trager James Chief Scientific Officer Feb 02, 2021 Sale $40.00 2,800 112,000 47,072 Feb 03, 2021, 07:48 PM
Trager James Chief Scientific Officer Feb 01, 2021 Sale $38.67 3,600 139,229 48,638 Feb 03, 2021, 07:48 PM
Mahmood Nadir See Remarks Jan 25, 2021 Option Exercise $3.89 5,500 21,395 36,988 Jan 26, 2021, 04:10 PM
Mahmood Nadir See Remarks Jan 25, 2021 Sale $48.57 5,500 267,120 34,988 Jan 26, 2021, 04:10 PM
Mahmood Nadir See Remarks Jan 14, 2021 Option Exercise $3.89 3,083 11,993 31,488 Jan 19, 2021, 10:06 AM
Mahmood Nadir See Remarks Dec 03, 2020 Option Exercise $3.89 3,000 11,670 28,405 Dec 07, 2020, 08:27 PM
GLAXOSMITHKLINE PLC Director Jul 14, 2020 Buy $18.00 833,333 14,999,994 3,150,732 Jul 16, 2020, 08:13 PM
New Enterprise Associates 15, L.P. 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
SANDELL SCOTT D 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
Sonsini Peter W. 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
Makhzoumi Mohamad 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
BASKETT FOREST 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
MAKOWER JOSHUA 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
Florence Anthony A. Jr. 10% Owner Jul 14, 2020 Buy $18.00 666,666 11,999,988 2,902,115 Jul 16, 2020, 05:00 PM
Novo Holdings A/S 10% Owner Jul 14, 2020 Buy $18.00 555,555 9,999,990 2,793,865 Jul 16, 2020, 04:41 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Jul 14, 2020 Buy $18.00 3,333,333 59,999,994 5,605,129 Jul 16, 2020, 04:30 PM
Flynn James E 10% Owner Jul 14, 2020 Buy $18.00 500,000 9,000,000 1,209,936 Jul 14, 2020, 11:39 AM
Flynn James E 10% Owner Jul 14, 2020 Buy $18.00 500,000 9,000,000 1,209,936 Jul 14, 2020, 11:39 AM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
HASTINGS PAUL J Chief Executive Officer 09/29/2021 231,051
Brandenberger Ralph See Remarks 09/01/2021 15,278
Brandenberger Ralph See Remarks 09/01/2021 132,811
Rajangam Kanya Chief Medical Officer 08/05/2021 4,100
Rajangam Kanya Chief Medical Officer 08/05/2021 372,800
Trager James Chief Scientific Officer 08/02/2021 8,753
Trager James Chief Scientific Officer 08/02/2021 113,508
Mahmood Nadir See Remarks 07/01/2021 13,615
Mahmood Nadir See Remarks 07/01/2021 206,115
HASTINGS PAUL J Chief Executive Officer 06/21/2021 226,218
Brandenberger Ralph See Remarks 06/02/2021 15,278
Brandenberger Ralph See Remarks 06/02/2021 101,430
HASTINGS PAUL J Chief Executive Officer 03/30/2021 522,540
Trager James Chief Scientific Officer 02/02/2021 50,400
Trager James Chief Scientific Officer 02/01/2021 8,753
Trager James Chief Scientific Officer 02/02/2021 112,000
Trager James Chief Scientific Officer 02/01/2021 139,229
Mahmood Nadir See Remarks 01/25/2021 21,395
Mahmood Nadir See Remarks 01/25/2021 267,120
Mahmood Nadir See Remarks 01/14/2021 11,993
Mahmood Nadir See Remarks 12/03/2020 11,670
GLAXOSMITHKLINE PLC Director 07/14/2020 14,999,994
New Enterprise Associates 15, L.P. 10% Owner 07/14/2020 11,999,988
SANDELL SCOTT D 10% Owner 07/14/2020 11,999,988
Sonsini Peter W. 10% Owner 07/14/2020 11,999,988
Makhzoumi Mohamad 10% Owner 07/14/2020 11,999,988
BASKETT FOREST 10% Owner 07/14/2020 11,999,988
MAKOWER JOSHUA 10% Owner 07/14/2020 11,999,988
Florence Anthony A. Jr. 10% Owner 07/14/2020 11,999,988
Novo Holdings A/S 10% Owner 07/14/2020 9,999,990
RA CAPITAL MANAGEMENT, L.P. 10% Owner 07/14/2020 59,999,994
Flynn James E 10% Owner 07/14/2020 9,000,000
Flynn James E 10% Owner 07/14/2020 9,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.12%
1Q
09/30/2021
03/31/2021
0.26%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.12%
1Q
03/31/2021
0.26%
2Q